Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

IMPORTANCE: To our knowledge, this is the first randomized trial in sex cord-stromal tumors, and it establishes weekly paclitaxel as standard-of-care therapy after platinum-based therapy in this setting. OBJECTIVE: To determine the efficacy of weekly paclitaxel with or without bevacizumab as treatme...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Oncol
Главные авторы: Ray-Coquard, Isabelle, Harter, Philipp, Lorusso, Domenica, Dalban, Cécile, Vergote, Ignace, Fujiwara, Keiichi, Gladieff, Laurence, Lück, Hans-Joachim, Floquet, Anne, Chevalier-Place, Annick, Schnelzer, Andreas, Pignata, Sandro, Selle, Frédéric, Sehouli, Jalid, Brocard, Fabien, Mangili, Giorgia, Pautier, Patricia, De Giorgi, Ugo, Provansal, Magali, Heudel, Pierre-Etienne
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2020
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545353/
https://ncbi.nlm.nih.gov/pubmed/33030515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.4574
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы